共 50 条
Does oral hygiene prevents nosocomial infections in hospitalized patients? A systematic review and meta-analysis
被引:0
|作者:
Miyahira, Karla Magnan
[1
]
Martins, Mariana Leonel
[1
]
Liberato, Walleska Freijo
[2
]
Magno, Marcela Barauna
[1
]
Ferreira, Dennis de Carvalho
[3
]
Tenorio, Jefferson R.
[4
]
Maia, Lucianne Cople
[1
]
Barbosa de Araujo Castro, Gloria Fernanda
[1
]
机构:
[1] Univ Fed Rio de Janeiro, Sch Dent, Dept Pediat Dent & Orthodont, Rio De Janeiro, RJ, Brazil
[2] Univ Fed Fluminense, Sch Dent, Dept Dent, Rio De Janeiro, RJ, Brazil
[3] Univ Estacio Sa, Sch Dent, Dept Dent, Rio De Janeiro, RJ, Brazil
[4] Univ Fed Rio de Janeiro, Sch Dent, Dept Pathol & Oral Diag, Rio De Janeiro, RJ, Brazil
来源:
MEDICINA ORAL PATOLOGIA ORAL Y CIRUGIA BUCAL
|
2025年
/
30卷
/
02期
关键词:
Nosocomial infections;
dental plaque;
intensive care patients;
oral decontamination;
chlorhexidine;
VENTILATOR-ASSOCIATED PNEUMONIA;
CARE-UNIT PATIENTS;
0.12-PERCENT CHLORHEXIDINE;
DECONTAMINATION;
GLUCONATE;
OROPHARYNGEAL;
COLONIZATION;
CHILDREN;
RISK;
D O I:
10.4317/medoral.26706
中图分类号:
R78 [口腔科学];
学科分类号:
1003 ;
摘要:
Background: This study aimed to evaluate the impact of oral hygiene (OH) with chlorhexidine (CHX) on the evolution of nosocomial infections (NI). Material and Methods: Electronic searches were carried out in PubMed, Scopus, Cochrane Library, Web of Science, VHL, and Grey Literature databases. Randomized clinical trials were included. Methodological quality and risk of bias were assessed using RoB 2.0. Meta-analyses were carried out comparing patients who did or did not receive OH with CHX (0.05%, 0.12% and 2%) for NI, Ventilator-Associated Pneumonia (VAP), S. aureus infection (SA), duration of mechanical ventilation (MV), length of hospital stay and Intensive Care Unit (ICU). The certainty of evidence (CE) was evaluated with GRADE approach. Results: Thirteen studies were selected for quantitative and qualitative synthesis. The risk for VAP (RR 0.72 [0.58, 0.90], p=0.003) and NI (RR 0.70 [0.58, 0.83], p<0.001) were lower in patients of the CHX groups compared to controls, independently for [CHX] used for NI (RR >= 0.49, p <= 0.03). Patients who received CHX 2x/day presented similar risk to control (RR 0.98 [0.75, 1.30], p=0.91); while 3 and 4x/day or more (RR >= 0.52, p <= 0.002) presented lower risk for NI. Similar risk for SA was observed among groups (RR 0.42 [0.14, 1.26], p=0.12). The average days of hospitalization (p=0.67), ICU stay (p=0.37) and MV (p=0.57) did not differ between the groups. CE ranged from very low to moderate. Conclusions: OH with CHX reduced NI, regardless of concentration, when used 3x/day or more. However, it had no effect against AS and did not reduce length of hospital stay.
引用
收藏
页码:e179 / e191
页数:13
相关论文